Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
EBIATLeasesOther Gross PP&E AdjustmentsReceivables - Other
Ratios

Summit Therapeutics (SMMT) Receivables - Net (2018 - 2022)

Summit Therapeutics (SMMT) has disclosed Receivables - Net for 4 consecutive years, with $349000.0 as the latest value for Q4 2022.

  • For the quarter ending Q4 2022, Receivables - Net fell 76.16% year-over-year to $349000.0, compared with a TTM value of $349000.0 through Dec 2022, down 76.16%, and an annual FY2022 reading of $349000.0, down 76.16% over the prior year.
  • Receivables - Net was $349000.0 for Q4 2022 at Summit Therapeutics, up from $140000.0 in the prior quarter.
  • Across five years, Receivables - Net topped out at $4.1 million in Q3 2020 and bottomed at $140000.0 in Q3 2022.
  • Average Receivables - Net over 4 years is $1.1 million, with a median of $541000.0 recorded in 2019.
  • The sharpest move saw Receivables - Net surged 342.3% in 2021, then tumbled 93.91% in 2022.
  • Year by year, Receivables - Net stood at $541000.0 in 2019, then plummeted by 38.82% to $331000.0 in 2020, then skyrocketed by 342.3% to $1.5 million in 2021, then plummeted by 76.16% to $349000.0 in 2022.
  • Business Quant data shows Receivables - Net for SMMT at $349000.0 in Q4 2022, $140000.0 in Q3 2022, and $238000.0 in Q2 2022.